Is central venous catheter in haemodialysis still the main factor of mortality after hospitalization?

Author:

Campos Erwin1,Cuevas-Budhart Miguel Angel2,Cedillo-Flores Renata3,Candelario-López Julian3,Jimenez Rigoberto4,Flores-Almonte Alberto5,Ramos-Sanchez Alfonso1

Affiliation:

1. Macrotech República Dominicana.

2. Mexican Social Security Institute

3. National Autonomous University of Mexico

4. hospital salvador a

5. CEMDOE: Centro Médico de Diabetes, Obesidad y Especialidades

Abstract

Abstract Background Haemodialysis is the most used Renal Replacement Therapy modality worldwide. But patients undergoing this treatment have an unpredictable evolution related to vascular access. Objective To determine the factors associated with the mortality and hospitalization rate in haemodialysis patients at a third-level care Center in the Dominican Republic. Methods This was an observational and prospective study involving a cohort of 192 haemodialysis patients. The patient selection was non-probabilistic for convenience, and a direct source questionnaire was applied. Results Of the 192 patients in the cohort, 103 (53.6%) were hospitalized and analysed. The most frequent cause of hospitalization was catheter-related bloodstream infections (53.4%). Almost one-third (28.2%) of the hospitalized patients died, mostly from infections13 (12.6%). Of those who died 29 patients, 90% had a Central venous catheter (CVC) with a non-tunnelled catheter (NTC) (65.5%). Having an NTC CVC makes a patient 85.5 times more likely to be hospitalized than patients with arteriovenous fistulas. Conclusion Vascular access plays a predominant role in the hospitalization and mortality rates in haemodialysis. Patients with an arteriovenous fistula obtained better outcomes than those with central venous catheters.

Publisher

Research Square Platform LLC

Reference19 articles.

1. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline;Stevens PE;Ann Intern Med,2013

2. Shirai N, Yamamoto S, Osawa Y, Tsubaki A, Morishita S, Narita I. Dynamic and static balance functions in hemodialysis patients and non-dialysis dependent CKD patients. Ther Apher Dial [Internet]. 2022 Sep 20 [cited 2022 Sep 22]; Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/1744-9987.13931.

3. A COVID-19 pandemic-specific, structured care process for peritoneal dialysis patients facilitated by telemedicine: Therapy continuity, prevention, and complications management;Polanco E;Ther Apher Dial 2021;(October,2020

4. Agarwal R, Flynn J, Pogue V, Rahman M, Reisin E, Weir MR. Assessment and Management of Hypertension in Patients on Dialysis. J Am Soc Nephrol [Internet]. 2014 Aug 1 [cited 2022 Sep 21];25(8):1630. Available from: /PMC/articles/PMC4116052/.

5. Gómez de la Torre-del, Carpio A, Bocanegra-Jesús A, Guinetti-Ortiz K, Mayta-Tristán P, Valdivia-Vega R. Mortalidad precoz en pacientes con enfermedad renal crónica que inician hemodiálisis por urgencia en una población peruana: Incidencia y factores de riesgo. Nefrología [Internet]. 2018;38(4):425–32. Available from: http://www.sciencedirect.com/science/article/pii/S0211699518300031.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3